Diversified portfolio of branded generics, generic drugs, advanced intermediates, nutraceuticals, & biosimilars
Present in 40+ countries with a portfolio of 800+ brands & 1,100+ filings across various international markets
Robust R&D network spanning India & the US

500+ Scientists across

6 R&D centers; 700+ product filings in international markets including 160+ ANDA filings

Multi-location manufacturing facilities with diversified capabilities
160 KL + capacity across 2 API manufacturing sites in India; facilities approved by US FDA, TGA, MFDS & UK MHRA
Alkem Laboratories
An integrated pharmaceuticals company

•World-class active pharmaceutical ingredient (API) research, development & manufacturing

 

•Innovative, competitive, regulatory-compliant process technology definition

 

•Comprehensive process analytical and scale-up safety assessment procedures /tools

 

•Diligent and effective international regulatory-compliant operations

•Solid phase synthesis of peptides using state of the art equipment with 200L capacity

 

•Preparatory high performance liquid chromatography with 450mm column & 8L/min capacity for product purification

 

•In-house lyophilization facility

 

•Wide pool of experienced & competent staff with support from Enzene, a competent Alkem subsidiary

We offer small molecule & peptide APIs

•cGMP compliant multipurpose plant with 3 dedicated modules

 

•SS, GL, & Hastelloy reactors 30L to 4KL capacity

 

•Containment facility & facilities for plant scale column chromatography & controlled crystallization

 

•Capability to handle reactions from -80◦C to 140 ◦C

 

•Capable of handling chlorination, bromination, sulfonation, reductive amination, esterification & chiral synthesis

 

•Approved by US FDA, MFDS Korea, TGA Australia

•cGMP compliant multipurpose plant with 3 dedicated modules

 

•SS & GL reactors up to 6.3KL capacity

 

•Dedicated facility for hydrogenation using 500L & 2000L stainless steel reactors

 

•Temperature controlled design to manage run-away reactions

 

•Solvent recovery plant with distillation capacity of 30KL/ day

 

•Approved by US FDA

We have 2 API facilities
Occupational & Product Safety

•ISO 14001 & ISO 45001 compliant Environment, Health & Safety policy

 

•~33K man-hours of EHS training conducted across manufacturing sites covering themes such as operations safety, risk management, emergency preparedness & behavioral safety1

Environment Management

•Zero Liquid discharge facilities at 64% of manufacturing units with 83% treated water usage1

 

•~5% share of solar power in average monthly power consumption1

•Formal Program for Energy efficiency, facility fuel efficiency, water usage/ wastage reduction
Energy efficiency & Carbon footprint reduction
Sustainability at Alkem
Our facilities are ISO 14001 & ISO 45001 certified

Mr. Basudeo N. Singh

Executive Chairman

•Co-founder of Alkem Laboratories

 

•Over 5 decades of experience in the Indian pharmaceutical industry

 

•Member of the Executive Council of the Indian

 

Pharmaceutical Alliance & former President of the Indian Drug Manufacturers' Association (2007-08)

Mr. Sandeep Singh

Managing Director

•Managing Director of Alkem Laboratories

 

•Over 2 decades of experience in the Indian pharmaceutical industry

 

•Overall responsibility for managing the domestic & international operations of Alkem Laboratories

Mrs. Madhurima Singh

Executive Director

•Extensive experience in the fields of legal & compliance, financial management, human resources, Supply chain management & marketing

 

•Responsible for managing the Active Pharmaceutical Ingredients business of Alkem, among other responsibilities

Our Leadership
About us
To achieve value driven leadership in healthcare industry through Quality that is infinite service that is admired and Hard work that endures
Welcome to Our Site